Synthesis and Biological Activity of Novel 1 H,3 H -Thiazolo[3,4- a ]Benzimidazoles: Non-nucleoside Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitors
Free accessResearch articleFirst published online August, 1999
Synthesis and Biological Activity of Novel 1 H,3 H -Thiazolo[3,4- a ]Benzimidazoles: Non-nucleoside Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitors
Using a known human immunodeficiency virus type 1 (HIV-1) nonnucleoside reverse transcriptase inhibitor (NNRTI), 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole (TBZ NSC 625487) as the lead structure for drug design, a series of novel 1H,3H-thiazolo[3,4-a]benzimidazole derivatives substituted on the benzene-fused ring was prepared. Their in vitro anti-HIV-1 activity, as well as their inhibitory effects on the viral reverse transcriptase, were evaluated. The structure-activity relationships for these compounds are described and the results suggest that the apolar binding pocket of RT, into which the NNRTIs must fit, can accommodate only groups with a limited size and shape.
ArticoM (1996) Nonnucleoside anti-HIV-1 reverse transcriptase inhibitors (NNRTIs): A chemical survey from lead compounds to selected drugs for clinical trials. Il Farmaco51: 305–331.
2.
BalzariniJPérez-PérezMJSan-FélixACamarasaMJBathurstICBarrPJ & De ClercqE (1992) Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2′,5′-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3′-spiro-5″ -(4″-amino-1″,2″-oxathiole-2″,2″-dioxide)thymine (TSAO-T). Journal of Biological Chemistry267: 11831–11838.
3.
BuckheitRWHollingsheadMGGermany-DeckerJWhiteELMcMahonJBAllenLBRossLJDeckerWDWestbrookLShannonWMWeislowOBaderJP & BoydMR (1993) Thiazolobenzimidazole: Biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor. Antiviral Research21: 247–265.
4.
ChimirriAGrassoSMonforteAMMonforteP & ZappalàM (1991a) Anti-HIV agents I. Synthesis and anti-HIV evaluation of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. Il Farmaco46: 817–823.
5.
ChimirriAGrassoSMonforteAMMonforteP & ZappalàM (1991b) Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. Il Farmaco46: 925–933.
6.
ChimirriAGrassoSMolicaCMonforteAMMonfortePZappalàM & ScopellitiR (1996) Anti-HIV agents IV. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazoles. Il Farmaco51: 279–282.
7.
ChimirriAGrassoSMolicaCMonforteAMMonfortePZappalàMBrunoGNicolòFWitvrouwMJonckeereHBalzariniJ & De ClercqE (1997a) Structural features and antihuman immunodeficiency virus (HIV) activity of the isomers of 1-(2′,6′-difluorophenyl)-1 H,3H-thiazolo[3,4-a]benzimidazole, a potent nonnucleoside HIV-1 reverse transcriptase inhibitor. Antiviral Chemistry & Chemotherapy8: 363–370.
8.
ChimirriAGrassoSMonforteAMMonfortePRaoA.ZappalàMBrunoGNicolòF & ScopellitiR (1997b) Anti-HIV agents V. Synthesis, structure and in vitro anti-HIV activity of novel 1 H,3H-naphtho[2′,3′:4,5]imidazo[1,2-c]thiazoles. Il Farmaco52: 673–677.
9.
ChimirriAGrassoSMonforteAMMonfortePRaoAZappalàMBrunoGNicolòFPannecouqueCWitvrouwM & De ClercqE (1998) Synthesis, structure and in vitro antihuman immunodeficiency virus activity of novel 3-methyl-1 H,3H-thiazolo[3,4-a]benzimidazole. Antiviral Chemistry & Chemotherapy9: 431–438.
10.
EsnoufRRenJRossCJonesYStammersD & StuartD (1995) Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors. Nature Structural Biology2: 303–308.
11.
Le GriceSFJ (1993) Human immunodeficiency virus reverse transcriptase. In Reverse Transcriptase, pp. 163–191. Edited by SkalkaAM and GoffSP. Plainview, NY: Cold Spring Harbor Laboratory Press.
12.
PauwelsRBalzariniJBabaMSnoeckRScholsDHerdewijinPDesmyterJ & De ClercqE (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. Journal of Virological Methods20: 309–321.
13.
SchultzRJBaderJPChimirriACoveyJMHillDLHaugwitzRDGuziecFS & NarayananVL (1992) Thiazolobenzimidazoles — A new class of anti-HIV agents. Proceedings of the American Association for Cancer Research33: 517.
14.
SpenceRAKatiWMAndersonKS & JohnsonKA (1995) Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors. Science267: 988–993
15.
TantilloCDingJJacobo-MolinaANanniRGBoyerPLHughesSHPauwelsRAndriesKJanssenPA & ArnoldE (1994) Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase: Implication for mechanisms of drug inhibition and resistance. Journal of Molecular Biology243: 369–387.
16.
WitvrouwMScholsDAndreiGSnoeckRHosoyaMPauwelsRBalzariniJ & De ClercqE (1991) Antiviral activity of low-MW dextran sulfate (derived from dextran MW 1000) compared to dextran sulfate samples of higher MW. Antiviral Chemistry & Chemotherapy2: 171–179.
